A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects

Phase 2 Terminated 126 enrolled High Point Pharmaceuticals, LLC.

RandomizedParallel-groupDouble-blindTreatment

The purpose of this study is to compare the safety and effect of HPP404 versus placebo on body weight in overweight or obese subjects.

Evaluation	Drug	Modality	Dose	Route
Subject	HPP404	Unknown	35 mg	Oral
Subject	HPP404	Unknown	50 mg	Oral